People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Endosee Corp | — | Biotechnology | Seed | $5.4M | $80.2M | 2011 |
| UroSee Corp | — | Other Health Care | Pre-Seed | $500K | $15.4M | 2017 |
Xiaolong (Bruce) OuYang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Xiaolong (Bruce) OuYang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Shih-Ping (Bob) Wang | 2 | 4 |
| Paul D. Indman | 1 | 1 |
| Kevin D. Rooney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.